Total Payments
$38,812
2024 Payments
$1,455
Companies
11
Transactions
38
Medicare Patients
751
Medicare Billing
$62,112
Payment Breakdown by Category
Consulting$31,281 (80.6%)
Other$4,518 (11.6%)
Travel$1,741 (4.5%)
Food & Beverage$1,253 (3.2%)
Education$19.32 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $31,281 | 13 | 80.6% |
| Honoraria | $3,300 | 2 | 8.5% |
| Travel and Lodging | $1,741 | 3 | 4.5% |
| Food and Beverage | $1,253 | 18 | 3.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,218 | 1 | 3.1% |
| Education | $19.32 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $13,438 | 6 | $0 (2022) |
| Avion Pharmaceuticals | $10,775 | 4 | $0 (2023) |
| IBSA Pharma Inc. | $6,339 | 15 | $0 (2023) |
| Acella Pharmaceuticals, LLC | $2,884 | 2 | $0 (2023) |
| Horizon Therapeutics plc | $1,800 | 1 | $0 (2022) |
| Novo Nordisk Inc | $1,582 | 5 | $0 (2024) |
| Ascendis Pharma, Inc. | $1,131 | 1 | $0 (2022) |
| IBSA Institut Biochimique SA | $702.41 | 1 | $0 (2018) |
| Xeris Pharmaceuticals, Inc. | $114.35 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $27.82 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,455 | 3 | Novo Nordisk Inc ($1,313) |
| 2023 | $1,757 | 6 | IBSA Pharma Inc. ($1,498) |
| 2022 | $5,460 | 4 | Amneal Pharmaceuticals LLC ($2,500) |
| 2021 | $21,657 | 8 | Amneal Pharmaceuticals LLC ($10,938) |
| 2020 | $2,748 | 2 | Acella Pharmaceuticals, LLC ($2,680) |
| 2019 | $3,129 | 5 | IBSA Pharma Inc. ($3,129) |
| 2018 | $2,405 | 7 | IBSA Pharma Inc. ($1,683) |
| 2017 | $201.13 | 3 | Novo Nordisk Inc ($201.13) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $114.35 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 05/08/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $27.82 | General |
| 02/22/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $1,312.50 | General |
| 09/29/2023 | Avion Pharmaceuticals | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $55.30 | General |
| Category: Hyperthyroidism | ||||||
| 09/28/2023 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | In-kind items and services | $122.21 | General |
| Category: Endocrinology | ||||||
| 09/28/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $33.03 | General |
| Category: non-opioid analgesic | ||||||
| 09/08/2023 | IBSA Pharma Inc. | Tirosint (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,217.96 | General |
| Category: Endocrinology | ||||||
| 06/15/2023 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $203.73 | General |
| Category: Hyperthyroidism | ||||||
| 06/15/2023 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrinology | ||||||
| 10/20/2022 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $28.79 | General |
| Category: Endocrinology | ||||||
| 09/13/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $1,800.00 | General |
| Category: TEPEZZA | ||||||
| 08/23/2022 | Amneal Pharmaceuticals LLC | — | Consulting Fee | In-kind items and services | $2,500.00 | General |
| 04/09/2022 | Ascendis Pharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,131.00 | General |
| 09/09/2021 | Amneal Pharmaceuticals LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 07/14/2021 | Avion Pharmaceuticals | — | Consulting Fee | Cash or cash equivalent | $2,010.00 | General |
| 07/01/2021 | Amneal Pharmaceuticals LLC | — | Consulting Fee | Cash or cash equivalent | $875.00 | General |
| 06/14/2021 | Avion Pharmaceuticals | — | Consulting Fee | Cash or cash equivalent | $2,680.00 | General |
| 06/06/2021 | Amneal Pharmaceuticals LLC | — | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| 04/29/2021 | Amneal Pharmaceuticals LLC | — | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| 04/14/2021 | Amneal Pharmaceuticals LLC | — | Consulting Fee | Cash or cash equivalent | $1,312.50 | General |
| 03/12/2021 | Avion Pharmaceuticals | — | Consulting Fee | Cash or cash equivalent | $6,029.99 | General |
| 08/13/2020 | Acella Pharmaceuticals, LLC | NP Thyroid (Drug) | Consulting Fee | Cash or cash equivalent | $2,680.00 | General |
| Category: Hyperthyroidism | ||||||
| 03/10/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $68.00 | General |
| 11/02/2019 | IBSA Pharma Inc. | Tirosint (Drug), Tirosint-SOL | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Endocrinology | ||||||
| 11/02/2019 | IBSA Pharma Inc. | Tirosint (Drug), Tirosint-SOL | Travel and Lodging | In-kind items and services | $584.66 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 208 | 296 | $76,447 | $19,492 |
| 2021 | 5 | 322 | 403 | $106,631 | $24,662 |
| 2020 | 7 | 221 | 362 | $73,967 | $17,958 |
Total Patients
751
Total Services
1,061
Medicare Billing
$62,112
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 112 | $22,624 | $6,149 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 49 | $14,553 | $4,280 | 29.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 55 | 61 | $18,117 | $4,110 | 22.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 19 | 19 | $9,082 | $1,670 | 18.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $5,532 | $1,599 | 28.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 14 | 14 | $4,004 | $1,101 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 11 | 11 | $2,211 | $529.78 | 24.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 17 | 18 | $324.00 | $53.28 | 16.4% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Facility | 2021 | 130 | 165 | $35,640 | $7,241 | 20.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 62 | 71 | $21,087 | $4,700 | 22.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 45 | $13,365 | $3,988 | 29.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 47 | $9,494 | $2,686 | 28.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $6,454 | $1,846 | 28.6% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2021 | 31 | 33 | $7,128 | $1,475 | 20.7% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 15 | 15 | $7,470 | $1,366 | 18.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 13 | 13 | $5,993 | $1,360 | 22.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 47 | 99 | $19,716 | $5,645 | 28.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 45 | 122 | $13,682 | $3,787 | 27.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 19 | 21 | $8,028 | $2,233 | 27.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 30 | 33 | $9,657 | $1,607 | 16.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 18 | $5,292 | $1,378 | 26.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 13 | 13 | $5,937 | $1,213 | 20.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 28 | 31 | $6,165 | $1,086 | 17.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 23 | 25 | $5,490 | $1,008 | 18.4% |
About Dr. Francesco Celi, M.D
Dr. Francesco Celi, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Farmington, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/02/2012. The National Provider Identifier (NPI) number assigned to this provider is 1427320761.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Francesco Celi, M.D has received a total of $38,812 in payments from pharmaceutical and medical device companies, with $1,455 received in 2024. These payments were reported across 38 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($31,281).
As a Medicare-enrolled provider, Celi has provided services to 751 Medicare beneficiaries, totaling 1,061 services with total Medicare billing of $62,112. Data is available for 3 years (2020–2022), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Farmington, CT
- Active Since 02/02/2012
- Last Updated 06/18/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1427320761
Products in Payments
- Tirosint (Drug) $7,009
- NP Thyroid (Drug) $2,680
- TEPEZZA (Drug) $1,800
- NP Thyroid 60 (Drug) $259.03
- RECORLEV (Drug) $114.35
- LICART (Drug) $33.03
- MACRILEN (Drug) $19.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Farmington
Dr. Navneet Kainth, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $3,026
Endocrinology, Diabetes & Metabolism $3,026
Carl Malchoff, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $2,048
Endocrinology, Diabetes & Metabolism $2,048
Joseph Lorenzo, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1,165
Endocrinology, Diabetes & Metabolism $1,165
Pamela Taxel, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1,148
Endocrinology, Diabetes & Metabolism $1,148
Vitaly Kantorovich, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $945.94
Endocrinology, Diabetes & Metabolism $945.94
Dr. Thomas Jones, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $562.64
Endocrinology, Diabetes & Metabolism $562.64